Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (NONSTOP)
Randomized Multicentric Open-label Phase III Clinical Trial to Evaluate the Efficacy of Continual Treatment Versus Discontinuation Based in the Presence of Prodromes in a First Episode of Non-affective Psychosis.
Sponsor: Fundación Pública Andaluza Progreso y Salud
Listed as NCT01765829, this PHASE3 trial focuses on Psychosis Nos/Other and remains ongoing. Sponsored by Fundación Pública Andaluza Progreso y Salud, it has been updated 7 times since 2012, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Nov 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundación Pública Andaluza Progreso y Salud
- Instituto de Salud Carlos III
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alcobendas, Spain , Andújar, Spain , Baza, Spain , Bilbao, Spain , Cártama, Spain , Dos Hermanas, Spain , Fuengiróla, Spain , Gandia, Spain , Madrid, Spain , Martos, Spain and 6 more locations